Sign in

    Gary Taylor

    Managing Director and Senior Equity Analyst at Cowen and Company

    Gary Taylor is a Managing Director and Senior Equity Analyst at TD Cowen specializing in healthcare services and insurance sectors. He notably covers companies such as UnitedHealth Group, P3 Health Partners, and other leading managed care and health services firms, and has achieved a documented 51.55% success rate with an average analyst return of 0.38%. Taylor’s career began over two decades ago, including roles at several investment banks before joining TD Cowen, where he became a recognized contributor to institutional healthcare equity research. He holds FINRA securities licenses and maintains active registrations, reflecting his professional credentials as a Wall Street research analyst.

    Gary Taylor's questions to AMEDISYS (AMED) leadership

    Gary Taylor's questions to AMEDISYS (AMED) leadership • Q4 2022

    Question

    Gary Taylor of Cowen and Company sought clarification on the full-year 2022 EBITDA loss for Contessa and the level of improvement assumed in the 2023 guidance, noting a potential discrepancy from prior expectations.

    Answer

    EVP, CFO & Acting COO Scott Ginn confirmed the 2022 Contessa loss was approximately $30 million and that the 2023 guidance embeds a similar loss, representing a flat year-over-year performance. He acknowledged this was behind their original plan, which had anticipated a ~$10 million improvement, attributing the change to the ramp-up of the new palliative care program and slower-than-expected progress with some JV relationships. Chairman and CEO Paul Kusserow added that they are focusing on scaling new, prestigious partners.

    Ask Fintool Equity Research AI